Cargando…

Intravenous pamidronate versus oral and intravenous clodronate in bone metastatic breast cancer: a randomized, open-label, non-inferiority Phase III trial

PURPOSE: Patients with metastasized breast cancer often suffer from discomfort caused by metastatic bone disease. Thus, osteoprotection is an important part of therapy in breast cancer metastasized to bone, and bisphosphonates (BPs) are a major therapeutic option. In this study, our objectives were...

Descripción completa

Detalles Bibliográficos
Autores principales:	von Au, Alexandra, Milloth, Eva, Diel, Ingo, Stefanovic, Stefan, Hennigs, Andre, Wallwiener, Markus, Heil, Joerg, Golatta, Michael, Rom, Joachim, Sohn, Christof, Schneeweiss, Andreas, Schuetz, Florian, Domschke, Christoph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4944913/ https://www.ncbi.nlm.nih.gov/pubmed/27468239 http://dx.doi.org/10.2147/OTT.S103130

Ejemplares similares

A randomised double-blind comparison of intravenous pamidronate and clodronate in the hypercalcaemia of malignancy.
por: Purohit, O. P., et al.
Publicado: (1995)

Parity improves anti-tumor immunity in breast cancer patients
por: Krause, Anna-Lena, et al.
Publicado: (2017)

Intravenous Pamidronate for Refractory Lymphedema
por: Beigi, A A, et al.
Publicado: (2011)

Intravenous pamidronate for refractory rheumatoid arthritis
por: Salesi, Mansour, et al.
Publicado: (2012)

Exam preparatory course for the 2nd part of the German medical examination in obstetrics and gynecology – a potential tool for the recruitment of new residents during the occupational decision process before the practical year?
por: Riedel, Fabian, et al.
Publicado: (2019)

Predictive value of neutrophil-to-lymphocyte-ratio in neoadjuvant-treated patients with breast cancer
por: von Au, Alexandra, et al.
Publicado: (2022)

High-dose intravenous pamidronate for metastatic bone pain.
por: Purohit, O. P., et al.
Publicado: (1994)

Acute Effects of Intravenous Administration of Pamidronate in Patients with Osteoporosis
por: Lim, Mie Jin, et al.
Publicado: (2010)

Effectiveness of the treatment with intravenous pamidronate in children with rheumatic diseases
por: Marco, A, et al.
Publicado: (2008)

Effective treatment of malignant hypercalcaemia with a single intravenous infusion of clodronate.
por: O'Rourke, N. P., et al.
Publicado: (1993)

Analyzing non-sentinel axillary metastases in patients with T3–T4 cN0 early breast cancer and tumor-involved sentinel lymph nodes undergoing breast-conserving therapy or mastectomy
por: Riedel, Fabian, et al.
Publicado: (2020)

Letter to the Editor: Acute Effects of Intravenous Administration of Pamidronate in Patients with Osteoporosis
por: Marcuzzi, Annalisa, et al.
Publicado: (2011)

The Author Response: Acute Effects of Intravenous Administration of Pamidronate in Patients with Osteoporosis
por: Park, Won
Publicado: (2011)

Efficacy and safety of intravenous pamidronate infusion for treating osteoporosis in children and adolescents
por: Yoon, Ji-Hee, et al.
Publicado: (2021)

Tumor biomarker conversion between primary and metastatic breast cancer: mRNA assessment and its concordance with immunohistochemistry
por: Stefanovic, Stefan, et al.
Publicado: (2017)

Analysis of survival following treatment of tumour-induced hypercalcaemia with intravenous pamidronate (APD).
por: Ling, P. J., et al.
Publicado: (1995)

Surgeon’s preference of subcutaneous tissue resection: most important factor for short-term complications in subcutaneous implant placement after mastectomy—results of a cohort study
por: Pfob, André, et al.
Publicado: (2020)

Changes in chemotherapy usage and outcome of early breast cancer patients in the last decade
por: Hennigs, A., et al.
Publicado: (2016)

ODP094 Hypercalcemia caused by Mycobacterium Avium Complex, with Excellent Response to Intravenous Pamidronate.
por: Khthir, Rodhan
Publicado: (2022)

Evaluation of Virtual Touch Tissue Imaging Quantification, a New Shear Wave Velocity Imaging Method, for Breast Lesion Assessment by Ultrasound
por: Golatta, Michael, et al.
Publicado: (2014)

Long-Term Patient Satisfaction and Quality of Life After Breast-Conserving Therapy: A Prospective Study Using the BREAST-Q
por: Stolpner, Ilona, et al.
Publicado: (2021)

Do hospital type or caseload make a difference in chemotherapy treatment patterns for early breast cancer? Results from 104 German institutions, 2008–2017
por: Riedel, Fabian, et al.
Publicado: (2021)

Treatment with intravenous pamidronate is a good alternative in case of gastrointestinal side effects or contraindications for oral bisphosphonates
por: Eekman, Danielle A, et al.
Publicado: (2009)

The stunning clodronate
por: Mass, Elvira
Publicado: (2023)

Prediction of local recurrence risk after neoadjuvant chemotherapy in patients with primary breast cancer: Clinical utility of the MD Anderson Prognostic Index
por: Michel, Laura L., et al.
Publicado: (2019)

First proof-of-concept evaluation of the FUSION-X-US-II prototype for the performance of automated breast ultrasound in healthy volunteers
por: Schaefgen, Benedikt, et al.
Publicado: (2021)

Evaluating the influence of music at different sound pressure levels on medical students’ performance of standardized laparoscopic box training exercises
por: Nees, Lisa Katharina, et al.
Publicado: (2021)

Height and weight development following cyclical intravenous pamidronate in children and adolescents with chronic recurrent multifocal osteomyelitis (CRMO)
por: Miettunen, PM, et al.
Publicado: (2008)

Treatment of Polyostotic Fibrous Dysplasia of the Thoracic Spine with Intravenous Pamidronate: Result from 9 Months Follow Up
por: Lee, Jongjoo, et al.
Publicado: (2015)

Detection of Human Papillomavirus Infection in Patients with Vaginal Intraepithelial Neoplasia
por: Lamos, Cristina, et al.
Publicado: (2016)

Effects of Adding Intravenous Pamidronate to Ongoing Menopausal Hormone Therapy in Postmenopausal Korean Women with Low Bone Mineral Density
por: Koo, Young-Ah, et al.
Publicado: (2019)

Molecular Subtype Conversion between Primary and Metastatic Breast Cancer Corresponding to the Dynamics of Apoptotic and Intact Circulating Tumor Cells
por: Stefanovic, Stefan, et al.
Publicado: (2019)

Cell-free circulating DNA integrity is an independent predictor of impending breast cancer recurrence
por: Cheng, Jie, et al.
Publicado: (2017)

Treatment of malignant hypercalcaemia with clodronate.
por: Percival, R. C., et al.
Publicado: (1985)

Learning curve for laparoscopic staging of early and locally advanced cervical and endometrial cancer
por: Tahmasbi Rad, Morva, et al.
Publicado: (2013)

Prognosis of breast cancer molecular subtypes in routine clinical care: A large prospective cohort study
por: Hennigs, André, et al.
Publicado: (2016)

Evaluation of the FUSION-X-US-II prototype to combine automated breast ultrasound and tomosynthesis
por: Schäfgen, Benedikt, et al.
Publicado: (2020)

Indirect osteoblast differentiation by liposomal clodronate
por: Okada, Emi, et al.
Publicado: (2017)

Is Breast Surgery Necessary for Breast Carcinoma in Complete Remission Following Neoadjuvant Chemotherapy?
por: Richter, Hannah, et al.
Publicado: (2018)

Impact of age on indication for chemotherapy in early breast cancer patients: results from 104 German institutions from 2008 to 2017
por: Hoffmann, Ann Sophie, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_o6i3qvc3hmj53ue3kdi5mcrlav